• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. PERCLOSE¿ PROSTYLE¿; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. PERCLOSE¿ PROSTYLE¿; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Model Number 12773-02
Medical Device Problem Code Failure to Cycle (1142)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/23/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The additional perclose prostyle devices referenced in b5 are filed under separate medwatch report numbers.
 
Event or Problem Description
It was reported that this was an arteriotomy closure of the right common femoral artery (rcfa) using the pre-close technique via prior to a thoracic endovascular aneurysm repair (tevar) interventional procedure.The sutures of the first prostyle device was successfully pre-placed.Reportedly, a cuff miss [suture retrieval issue] occurred with six prostyle devices in a row.The tevar procedure was abandoned at the rcfa.Hemostasis was achieved with the pre-placed prostyle suture in the rcfa.The sutures of two new prostyle devices were successfully pre-placed without issue contralaterally.The sheath was upsized to a large bore sheath and the tevar procedure was continued contralaterally.Hemostasis was achieved with the preplaced prostyle sutures on the contralateral access site.There was no reported adverse patient sequela and no reported clinically significant delay in the procedure or therapy.No additional information was provided.
 
Additional Manufacturer Narrative
Visual inspections were performed on the returned device.The reported needle to cuff miss was confirmed.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.The reported difficulties and subsequent treatment appear to be related to an interaction of the device with patient anatomy or inability to maintain position/stability of the device during deployment due to circumstances of the procedure.Based on the results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCLOSE¿ PROSTYLE¿
Common Device Name
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20623795
Report Number2024168-2024-13053
Device Sequence Number8168610
Product Code MGB
UDI-Device Identifier08717648344039
UDI-Public(01)08717648344039(17)260531(10)4061242
Combination Product (Y/N)N
Initial Reporter CountryHK
PMA/510(K) Number
P960043
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number12773-02
Device Catalogue Number12773-02
Device Lot Number4061242
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/23/2024
Supplement Date Received by Manufacturer12/10/2024
Initial Report FDA Received Date11/06/2024
Supplement Report FDA Received Date12/30/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
VESSEL CLOSURE: PROSTYLE
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-